Evidence map›Paper›PMID 20424230›Full record

ArticleDiabetes2010

Cumulative risk, age at onset, and sex-specific differences for developing end-stage renal disease in young patients with type 1 diabetes: a nationwide population-based cohort study.

Anna Möllsten, Maria Svensson, Ingeborg Waernbaum, Yonas Berhan, Staffan Schön, Lennarth Nyström, Hans J Arnqvist, Gisela Dahlquist, Swedish Childhood Diabetes Study Group, Diabetes Incidence Study in Sweden and 1 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Diabetes, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03835312 (Sequential Transplantation of Umbilical Cord Blood Stem Cells and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency Type 1 Diabetes Mellitus), which is not on this map. Cited by 47 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 3 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03835312 narecruitingnot on this mapstarted 2019, after this paper: background citation

Sequential Transplantation of Umbilical Cord Blood Stem Cells and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency Type 1 Diabetes Mellitus

TypeinterventionalSponsorChildren's Hospital of Fudan UniversityRan2019 to 2030Enrolled50ConditionsDiabetes Mellitus, Type 1, Immunologic Deficiency SyndromesArmsSequential transplantation
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 3 syntheses or guidelines pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Role of sex hormones in diabetic nephropathy.Frontiers in endocrinology · 2023
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Anna MöllstenDepartment of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden. anna.mollsten@pediatri.umu.se
Maria Svensson
Ingeborg Waernbaum
Yonas Berhan
Staffan Schön
Lennarth Nyström
Hans J Arnqvist
Gisela Dahlquist
Swedish Childhood Diabetes Study Group
Diabetes Incidence Study in Sweden
Swedish Renal Registry
Umeå University · SELinköping University · SERyhov Hospital Jönköping · SESahlgrenska University Hospital · SESunderby sjukhus · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to estimate the current cumulative risk of end-stage renal disease (ESRD) due to diabetic nephropathy in a large, nationwide, population-based prospective type 1 diabetes cohort and specifically study the effects of sex and age at onset. RESEARCH DESIGN AND

methodsIn Sweden, all incident cases of type 1 diabetes aged 0-14 years and 15-34 years are recorded in validated research registers since 1977 and 1983, respectively. These registers were linked to the Swedish Renal Registry, which, since 1991, collects data on patients who receive active uremia treatment. Patients with > or =13 years duration of type 1 diabetes were included (n = 11,681).

resultsDuring a median time of follow-up of 20 years, 127 patients had developed ESRD due to diabetic nephropathy. The cumulative incidence at 30 years of type 1 diabetes duration was low, with a male predominance (4.1% [95% CI 3.1-5.3] vs. 2.5% [1.7-3.5]). In both male and female subjects, onset of type 1 diabetes before 10 years of age was associated with the lowest risk of developing ESRD. The highest risk of ESRD was found in male subjects diagnosed at age 20-34 years (hazard ratio 3.0 [95% CI 1.5-5.7]). In female subjects with onset at age 20-34 years, the risk was similar to patients' diagnosed before age 10 years.

conclusionsThe cumulative incidence of ESRD is exceptionally low in young type 1 diabetic patients in Sweden. There is a striking difference in risk for male compared with female patients. The different patterns of risk by age at onset and sex suggest a role for puberty and sex hormones.

Indexed as

Age of OnsetAdolescentAdultChildChild, PreschoolCohort StudiesDiabetes Mellitus, Type 1Diabetic NephropathiesFemaleHumansIncidenceInfantKaplan-Meier EstimateKidney Failure, ChronicMaleRegistries

Identifiers

PMID20424230
PMCPMC2889782
OpenAlexW2170890311

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.